Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study.

Aikaterini DetorakiEugenio TremanteMaria D'AmatoCecilia CalabreseClaudia CasellaMauro ManiscalcoRemo PotoRaffaele BrancaccioMatilde BocciaMaria MartinoClara ImperatoreGiuseppe Spadaro

Published in: Therapeutic advances in respiratory disease (2022)

Mepolizumab improves sino-nasal and asthma symptoms and reduces polyp growth in patients with severe eosinophilic asthma and concomitant CRSwNP in real life.The reviews of this paper are available via the supplemental material section.

Keyphrases

chronic rhinosinusitis
chronic obstructive pulmonary disease
lung function
allergic rhinitis
early onset
cystic fibrosis
air pollution
sleep quality
randomized controlled trial
systematic review
drug induced